These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37653287)

  • 1. Risk of metastasis and survival in patients undergoing different treatment strategies with T1 colonic neuroendocrine tumors.
    Wu X; Peng C; Lin M; Li Z; Yang X; Liu J; Yang X; Zuo X
    J Endocrinol Invest; 2024 Mar; 47(3):671-681. PubMed ID: 37653287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastasis Prevalence and Survival of Patients with T1-2 Gastric Neuroendocrine Tumor Treated with Endoscopic Therapy and Surgery.
    Wang M; Cheng S; Zhu L; Xu T; Zhang J; Zhang Y; Ping J; Wang R
    Dig Dis Sci; 2022 Jul; 67(7):3228-3238. PubMed ID: 34272627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic and surgical treatment of T1N0M0 colorectal neuroendocrine tumors: a population-based comparative study.
    Zhu H; Zhao S; Zhang C; Ji K; Wu W; Yin L; Yan H; Zhou J; Tang R; Miao L
    Surg Endosc; 2022 Apr; 36(4):2488-2498. PubMed ID: 33987767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for lymph node metastasis and survival of patients with nonampullary duodenal carcinoid tumors treated with endoscopic therapy versus surgical resection: analysis of the Surveillance, Epidemiology, and End Results program.
    Wang R; Mohapatra S; Jovani M; Akshintala VS; Kamal A; Brewer OG; Kumbhari V; Shin EJ; Canto MI; Khashab MA; Singh VK; Lennon AM; Kalloo AN; Ngamruengphong S
    Gastrointest Endosc; 2021 Jun; 93(6):1384-1392. PubMed ID: 33347833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes of 1-2 cm rectal neuroendocrine tumors after local excision or radical resection: A population-based multicenter study.
    Li C; Yu M; Liu W; Zhang W; Jiang W; Zhang P; Zeng X; Di M; Liao X; Zheng Y; Xiong Z; Xia L; Sun Y; Zhang R; Zhong M; Lin G; Lin R; Tao K
    Heliyon; 2024 Apr; 10(7):e28335. PubMed ID: 38571595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factor Analysis of Lymph Node Metastasis for Rectal Neuroendocrine Tumors: Who Needs a Radical Resection in Rectal Neuroendocrine Tumors Sized 1-2 cm?
    Choi JS; Kim MJ; Shin R; Park JW; Heo SC; Jeong SY; Park KJ; Ryoo SB
    Ann Surg Oncol; 2024 Apr; 31(4):2414-2424. PubMed ID: 38194045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of Lymph Node Metastasis in Patients With T1/T2 Gastroduodenal Neuroendocrine Neoplasms: Implications for Endoscopic Treatment.
    Zhou YJ; Wang QW; Zhang QW; Chen JN; Wang XY; Gao YJ; Li XB
    Front Endocrinol (Lausanne); 2021; 12():658392. PubMed ID: 34122337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Size Criteria Is Not Sufficient in Selecting Patients for Local Excision Versus Radical Excision for Rectal Neuroendocrine Tumors >2 cm: A National Cancer Database Analysis.
    Izquierdo KM; Humphries MD; Farkas LM
    Dis Colon Rectum; 2021 Apr; 64(4):399-408. PubMed ID: 33651006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a nomogram model to predict survival outcomes in patients with primary hepatic neuroendocrine tumors based on SEER database.
    Zhang Z; Zhao X; Li Z; Wu Y; Liu Y; Li Z; Li G
    BMC Cancer; 2021 May; 21(1):567. PubMed ID: 34006241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of metastasis and survival of 788 patients with T1 rectal carcinoid tumors.
    Ngamruengphong S; Kamal A; Akshintala V; Hajiyeva G; Hanada Y; Chen YI; Sanaei O; Fluxa D; Haito Chavez Y; Kumbhari V; Singh VK; Lennon AM; Canto MI; Khashab MA
    Gastrointest Endosc; 2019 Mar; 89(3):602-606. PubMed ID: 30447216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparable survival benefit of local excision versus radical resection for 10- to 20-mm rectal neuroendocrine tumors.
    Chen Q; Chen J; Huang Z; Zhao H; Cai J
    Eur J Surg Oncol; 2022 Apr; 48(4):864-872. PubMed ID: 34753616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary neuroendocrine tumors of the ovary: Management and outcomes.
    Pang L; Guo Z
    Cancer Med; 2021 Dec; 10(23):8558-8569. PubMed ID: 34773393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of Lymph Node Metastasis and Optimal Surgical Strategy in Small (≤20 mm) Gastroenteropancreatic Neuroendocrine Tumors.
    Cai Y; Liu Z; Jiang L; Ma D; Zhou Z; Ju H; Zhu Y
    Front Endocrinol (Lausanne); 2022; 13():871830. PubMed ID: 35937823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival in patients with neuroendocrine tumors of the colon, rectum and small intestine.
    Keller HR; Senapathi SH; Morada A; Bertsch D; Cagir B
    Am J Surg; 2023 Jan; 225(1):58-65. PubMed ID: 36216612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duodenal neuroendocrine tumors: Somewhere between the pancreas and small bowel?
    Gamboa AC; Liu Y; Lee RM; Zaidi MY; Staley CA; Kooby DA; Winer JH; Shah MM; Russell MC; Cardona K; Maithel SK
    J Surg Oncol; 2019 Dec; 120(8):1293-1301. PubMed ID: 31621090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparable long-term survival outcomes of endoscopic therapy versus surgical therapy for T1-2N0M0 duodenal neuroendocrine tumors.
    Liu Z; Gao J; Wang P; Yin F; Zeng C; Chen Y
    Surg Endosc; 2023 Jul; 37(7):5444-5452. PubMed ID: 37036503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second primary cancers and survival among neuroendocrine tumor patients.
    Bateni SB; Coburn NG; Law C; Singh S; Myrehaug S; Assal A; Hallet J
    Endocr Relat Cancer; 2023 Aug; 30(8):. PubMed ID: 37184947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factors for Lymph Node Metastasis and Survival Outcomes in Colorectal Neuroendocrine Tumors.
    Wu Z; Wang Z; Zheng Z; Bi J; Wang X; Feng Q
    Cancer Manag Res; 2020; 12():7151-7164. PubMed ID: 32848469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors, prognostic factors, and nomograms for distant metastases in patients with gastroenteropancreatic neuroendocrine tumors: a population-based study.
    Li X; Fan Y; Tong J; Lou M
    Front Endocrinol (Lausanne); 2024; 15():1264952. PubMed ID: 38449852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of primary tumor resection on the survival of patients with unresectable colon cancer liver metastasis at different colonic subsites: a propensity score matching analysis.
    Zhao J; Zhu J; Huang C; Yuan R; Zhu Z
    Acta Chir Belg; 2023 Apr; 123(2):132-147. PubMed ID: 34278951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.